Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesMolecular ImagingSNMMI: Retreatment with Lu-177 PSMA-617 shows promise in mCRPC patientsRetreatment with Lu-177 PSMA-617 is emerging as a potential approach in men with prostate cancer.Nuclear MedicineSNMMI: New PET tracers developed for imaging brain disordersMolecular ImagingSNMMI: SPECT/CT valuable after Lu-177 therapyWomens ImagingDL model improves detection of breast arterial calcificationsSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!